K
Watchlist
← Dealbook
Amperos logoAM

Amperos

Healthcare & Life Sciences / Digital Health/HealthTech / Electronic Health Records
B
5 risks

Amperos is applying agentic architectures to healthcare, representing a series a vertical AI play with core generative AI integration.

www.amperos.com
series aGenAI: coreNew York, United States
$16.0Mraised
5KB analyzed6 quotesUpdated May 1, 2026
Event Timeline
Why This Matters Now

As agentic architectures emerge as the dominant build pattern, Amperos is positioned to benefit from enterprise demand for autonomous workflow solutions. The timing aligns with broader market readiness for AI systems that can execute multi-step tasks without human intervention.

Amperos is an AI-powered revenue recovery and denial management platform that reduces claim rejections and optimize collections.

Core Advantage

The combination of agentic AI that can autonomously process and pursue claims end-to-end + curated human RCM expertise and configurable, client-specific workflow mapping, all integrated into provider EHR/PM ecosystems.

Build SignalsFull pattern analysis

Agentic Architectures

3 quotes
high

The product explicitly frames autonomous agents that act on claims end-to-end, performing multi-step actions (prioritization, follow-ups, resubmission) and using tool-like integrations with EHR/PM systems, with human experts supervising escalations.

What This Enables

Full workflow automation across legal, finance, and operations. Creates new category of "AI employees" that handle complex multi-step tasks.

Time Horizon12-24 months
Primary RiskReliability concerns in high-stakes environments may slow enterprise adoption.

Continuous-learning Flywheels

3 quotes
medium

The platform captures rich interaction and outcome data and performs analytics across payors and workflows, suggesting a feedback loop where outcomes and interaction logs could be used to improve prioritization, models, and workflows over time.

What This Enables

Winner-take-most dynamics in categories where well-executed. Defensibility against well-funded competitors.

Time Horizon24+ months
Primary RiskRequires critical mass of users to generate meaningful signal.

RAG (Retrieval-Augmented Generation)

3 quotes
emerging

There are signs of a centralized claims and interaction store used to inform agent behavior and summaries; while not explicit about vectors/embeddings, the integration with EHR/PM systems and captured summaries imply retrieval of contextual documents or records to support generation and decisions.

What This Enables

Accelerates enterprise AI adoption by providing audit trails and source attribution.

Time Horizon0-12 months
Primary RiskPattern becoming table stakes. Differentiation shifting to retrieval quality.

Vertical Data Moats

3 quotes
medium

The product targets a narrow vertical (healthcare claims/RCM) and appears to collect provider- and payor-specific claims data and patterns, which can serve as proprietary, industry-specific training data and a competitive advantage.

What This Enables

Unlocks AI applications in regulated industries where generic models fail. Creates acquisition targets for incumbents.

Time Horizon0-12 months
Primary RiskData licensing costs may erode margins. Privacy regulations could limit data accumulation.
Model Architecture
Compound AI System

Agentic autonomous agents orchestrate claim-level tasks (first-touch, resubmission, follow-ups) with explicit human RCM oversight and deployment-time mapping of SOPs into agent workflows. No evidence provided for multi-model handoffs or model-to-model orchestration.

Team
Michal Miernowski• CEO & Co-Founderhigh technical

Not specified in provided content

Unknown• Chief Product Officer & Co-Foundermedium technical

Not specified in provided content

Unknown• Chief Technology Officer & Co-Founderhigh technical

Not specified in provided content

Founder-Market Fit

The founders' stated roles and focus align with healthcare RCM automation and AI-enabled denial management; however explicit prior healthcare experience for Michal and the other co-founders is not disclosed, limiting confidence in market-fit from public info.

Engineering-heavyML expertiseDomain expertiseHiring: RCM/healthcare domain expertsHiring: engineering/software roles (AI/automation)Hiring: deployment/solutions engineering
Considerations
  • • Lack of disclosed names/backgrounds for two co-founders
  • • Limited public detail on prior work experience, funding, or advisors
  • • No explicit information about team size or engineering headcount
Business Model
Go-to-Market

sales led

Target: enterprise

Pricing

custom

Enterprise focus
Sales Motion

hybrid

Distribution Advantages
  • • Extensive integrations with leading EHR and practice management systems (eClinicalWorks, Athenahealth, NextGen, Epic, ModMed, Imagine, Dentrix)
Customer Evidence

• Trusted by leading healthcare providers and RCM teams

• Claims processed across leading healthcare providers

• Integrations with multiple major EHRs

Product
Stage:general availability
Differentiating Features
Agentic AI driving end-to-end claim recoveryCombination of AI agents and tenured RCM specialists for complex denialsConfigurable rules-based workflow customization with SOP alignment
Integrations
eClinicalWorksAthenahealthNextGenEpicModMedImagine
Primary Use Case

End-to-end insurance claim collections and denial management for healthcare providers

Novel Approaches
Agentic autonomous claim-handling agents with human oversightNovelty: 7/10Compound AI Systems

Applying agentic AI to entire revenue cycle management with explicit human-in-the-loop oversight and real operational handoffs is an application-level novelty — it operationalizes autonomy in a highly regulated, document-driven vertical where full automation is uncommon.

Competitive Context

Amperos operates in a competitive landscape that includes Olive, Waystar, R1 RCM.

Olive

Differentiation: Amperos emphasizes agentic AI that works claims end-to-end combined with a human RCM specialist layer for complex denials, configurable provider-specific workflows, and explicit first-touch denial automation; Olive positions more as broad workflow automation and RPA across many back-office functions rather than a denial-specialist that pursues claims through outcome.

Waystar

Differentiation: Waystar is a heavyweight RCM/claims processing platform focused on eligibility, claims, and patient billing at scale; Amperos differentiates by claiming agentic autonomous claim work (AI agents pursuing claims) plus a service element of tenured RCM experts and configurable SOP mapping for higher-touch denial recovery rather than primarily workflow tooling and dashboards.

R1 RCM

Differentiation: R1 is an operations-first outsourcer relying on human teams and large-scale managed services; Amperos combines autonomous AI agents to do first-touch and end-to-end claim work to reduce cost-to-collect and AR backlog, offering a hybrid product+expert model rather than pure outsourcing.

Notable Findings

Agentic AI + human-in-the-loop RCM: They explicitly pair 'agentic AI' that works claims end-to-end with tenured revenue cycle management (RCM) experts providing oversight. That implies an orchestration layer running autonomous agents for claim actions (resubmissions, appeals, payer communications) with escalation hooks and human review gates — a hybrid autonomy design rather than pure human augmentation or pure automation.

Workflow-as-code mapped to provider SOPs and payor priorities: The product claims to 'map your exact workflows, payor priorities, and SOPs' into the system. This suggests a configurable workflow engine or DSL that codifies institutional rules and payor-specific business logic, enabling per-client policy configuration rather than one-size-fits-all ML.

Closed-loop outcome learning and prioritization: Repeated emphasis on higher recovery, prioritized workqueues, and analytics identifying payor and denial patterns implies they feed claim outcomes back into models/heuristics to refine triage and prioritization. That creates a learning loop (supervised signal = recovered revenue) uncommon in simple rule-based RPA.

Multi-modal automation surface: Claims are 'worked end-to-end' including first-touch automation, resubmission, follow-ups and payor interactions — meaning integrations span EHR/PM APIs, EDI (X12 837/835), payer portals (likely via RPA/selenium-like tooling), and natural language outputs (appeals letters, phone scripts). Managing all these modalities is technically unusual in depth and breadth.

Claim-centric observability and accountability: Every interaction, update, decision is 'captured and summarized' which points to a claim-level event store and automated summarization pipeline (likely LLM-based) to produce readable audit trails — tying model decisions to outcomes for compliance and human review.

Risk Factors
Overclaiminghigh severity
No Clear Moatmedium severity
Feature, Not Productmedium severity
Wrapper Riskmedium severity
What This Changes

Amperos's execution will test whether agentic architectures can deliver sustainable competitive advantage in healthcare. A successful outcome would validate the vertical AI thesis and likely trigger increased investment in similar plays. Incumbents in healthcare should monitor closely for early signs of customer adoption.

Source Evidence(6 quotes)
“A new standard for insurance collections Amperos uses agentic AI to recover insurance revenue end-to-end”
“AI agents work claims end-to-end, while Amperos RCM experts provide oversight and guidance for resolving complex denials and escalations”
“Our combination of AI optimization and a team of tenured revenue cycle specialists”
“Hybrid agentic system explicitly paired with tenured RCM specialists for human-in-the-loop escalation and domain validation (tight human+agent workflow)”
“Configurable deployment that maps customer-specific SOPs and payor priorities into agent workflows (customer-driven rule ingestion and behavior mapping)”
“End-to-end claim agent that integrates bi-directionally with multiple EHR/PM systems (Epic, Athenahealth, eClinicalWorks, etc.) to run automated follow-ups and resubmissions as actionable tool use”